Qwadra secures exclusive license for BEGO Medical's 3D band printing technology for orthopedic insoles

Qwadra, the parent company of PodoPrinter, has entered into an exclusive licensing agreement with BEGO Medical GmbH for a patented 3D band printing technology. The deal grants Qwadra exclusive commercial rights to deploy the technology specifically for the continuous production of orthopedic foot insoles. The 3D band printing process, which prints on a moving conveyor belt rather than a fixed platform, enables serial production of individualized parts from scan or CAD data. Qwadra CEO Luc Boronat stated the agreement validates the company's positioning in a demanding segment and will support expanded investment in development, service, and international commercialization.

This deal fits a recurring pattern in additive manufacturing where specialized, application-specific IP becomes the basis for market capture rather than general-purpose machine sales. The orthopedic insole segment is a rare case where AM's promise of mass customization meets real production economics: insoles require patient-specific geometry, reproducible material properties, and clinical-grade durability, but have traditionally relied on manual craftsmanship. By securing exclusive rights to a continuous band-printing process, Qwadra is betting that process repeatability and throughput - not just design freedom - will unlock broader adoption among podology labs and orthopedic technicians. The arrangement also reflects the growing importance of materials and process governance in medical AM, where the value lies not in the printer alone but in the validated, repeatable production chain.

For Qwadra, the immediate priority is translating this IP exclusivity into a defensible service and machine ecosystem that podology practices can actually adopt without retooling their entire workflow. The company must demonstrate that band printing delivers consistent part quality across production runs, not just in demo settings. For buyers, the key question is whether the licensed process reduces per-unit cost and lead time compared to traditional milling or manual fabrication - if it does, this deal could accelerate digital adoption in a historically conservative segment.